Trospium Chloride NDC 90096-141

NDC codes

FDA NDC Directory

Product NDC (as listed)90096-141Labeler and product segments. Claims need a package NDC.

Product NDC at billing width90096-0141Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
90096-141-60	90096014160	60 TABLET, FILM COATED in 1 BOTTLE (90096-141-60)Marketed from Dec 3, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Trospium Chloride
Generic name (nonproprietary): trospium chloride
Active ingredients: Trospium chloride — 20 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Zameer Pharmaceuticals LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215781
Marketing start: Dec 3, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Cholinergic Muscarinic Antagonists (Mechanism)
Identifiers: Product ID 90096-141_415ee086-d26e-4e82-a350-036f5f879256SPL ID 415ee086-d26e-4e82-a350-036f5f879256SPL set ID 048b4bc7-c77e-40fc-9bfb-bb35c6a3f871RxCUI 857560UNII 1E6682427EUPC 0390096141603
Pharmacologic class: Cholinergic Muscarinic Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N490096014160 followed by a unit qualifier and the quantity

Package 90096-0141-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 19, 2024.

Indications (excerpt from the label)

Trospium chloride tablets is a muscarinic antagonist indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency. Trospium chloride tablets is a muscarinic antagonist indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)